Release Date: 05/12/23 09:16 Summary: Transaction Booklet Lodged with ASIC Price Sensitive: Yes Download Document 132.2KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%